[HTML][HTML] Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
…, M Somasundaran, JL Sullivan, K Luzuriaga… - Nature, 2003 - nature.com
Spike (S) proteins of coronaviruses, including the coronavirus that causes severe acute
respiratory syndrome (SARS), associate with cellular receptors to mediate infection of their target …
respiratory syndrome (SARS), associate with cellular receptors to mediate infection of their target …
[HTML][HTML] Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection
K Luzuriaga, Y Bryson, P Krogstad… - … England Journal of …, 1997 - Mass Medical Soc
Background In infants and children with maternally acquired human immunodeficiency virus
type 1 (HIV-1) infection, treatment with a single antiretroviral agent has limited efficacy. We …
type 1 (HIV-1) infection, treatment with a single antiretroviral agent has limited efficacy. We …
[HTML][HTML] Absence of detectable HIV-1 viremia after treatment cessation in an infant
…, M Strain, D Richman, K Luzuriaga - … England Journal of …, 2013 - Mass Medical Soc
<p id="p001">An infant born to a woman with human immunodeficiency virus type 1 (HIV-1)
infection began receiving antiretroviral therapy (ART) 30 hours after birth owing to high-risk …
infection began receiving antiretroviral therapy (ART) 30 hours after birth owing to high-risk …
Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses
K Luzuriaga, M McManus, M Catalina… - Journal of …, 2000 - Am Soc Microbiol
Studies of potent antiretroviral combination regimens were undertaken in young infants to
evaluate the potential for long-term suppression of viral replication and to evaluate the …
evaluate the potential for long-term suppression of viral replication and to evaluate the …
Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study
…, DW Wara, SD Douglas, K Luzuriaga… - Journal of Allergy and …, 2003 - Elsevier
BACKGROUND: Peripheral blood lymphocyte subsets need to be determined in a large,
urban, minority-predominant cohort of healthy children to serve as suitable control subjects for …
urban, minority-predominant cohort of healthy children to serve as suitable control subjects for …
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
…, I Teo, T Greenough, N Sharova, K Luzuriaga… - Nature medicine, 2000 - nature.com
Abstract Treatment of HIV-1-infected individuals with a combination of anti-retroviral agents
results in sustained suppression of HIV-1 replication, as evidenced by a reduction in plasma …
results in sustained suppression of HIV-1 replication, as evidenced by a reduction in plasma …
Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo
…, M Catalina, JL Sullivan, K Luzuriaga… - Proceedings of the …, 2004 - National Acad Sciences
Epstein-Barr virus (EBV) is a herpesvirus that establishes a lifelong, persistent infection. It
was first discovered in the tumor Burkitt's lymphoma (BL). Despite intensive study, the role of …
was first discovered in the tumor Burkitt's lymphoma (BL). Despite intensive study, the role of …
[HTML][HTML] Viremic relapse after HIV-1 remission in a perinatally infected child
K Luzuriaga, H Gay, C Ziemniak… - … England Journal of …, 2015 - Mass Medical Soc
… Persaud and Luzuriaga; AI1097265, to Dr. Luzuriaga; and F32 AI108414, to Dr. Sanborn),
the Johns Hopkins University Center for AIDS Research (P30AI094189, to Dr. Persaud), the …
the Johns Hopkins University Center for AIDS Research (P30AI094189, to Dr. Persaud), the …
Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells
…, T Souza, M Catalina, JL Sullivan, K Luzuriaga… - Journal of …, 2004 - Am Soc Microbiol
In this paper we demonstrate that during acute infection with Epstein-Barr virus (EBV), the
peripheral blood fills up with latently infected, resting memory B cells to the point where up to …
peripheral blood fills up with latently infected, resting memory B cells to the point where up to …
On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis
…, JL Sullivan, K Luzuriaga… - Blood, The Journal …, 2008 - ashpublications.org
Memory B cells latently infected with Epstein-Barr virus (mB Lats ) in the blood disappear
rapidly on presentation with acute symptomatic primary infection (acute infectious …
rapidly on presentation with acute symptomatic primary infection (acute infectious …